French reorganization for funding worries researchers

The French government's long-awaited blueprint for reforming the country's research system, recently unveiled, has sparked fears that it will result in less money being available for basic research.

Written byJane Burgermeister
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The French government's long-awaited blueprint for reforming the country's research system, recently unveiled, has sparked fears that it will result in less money being available for basic research.

The impending reorganization has already prompted numerous protests in recent months, and roughly 5000 scientists took to the streets of Paris and other French cities in May to voice their opposition to government plans to reform the system for evaluating and funding research. Some scientists fear the shake up could lead to established research organizations such as the National Center for Scientific Research (CNRS) and the National Institute for Health and Medical Research (INSERM) being eclipsed by the new national grant agency, the National Research Agency (NRA).

The NRA, which came into operation in April this year, will have an annual budget of $441 million (US) to finance both basic and applied research projects chosen on merit by an international peer review ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies